The Prevention GENEration program was established by Rosa Dembitzer after personally surviving hereditary breast and ovarian cancer caused by BRCA 1 hereditary mutation. The program was launched in conjunction with the Israel Cancer Association and the Israel Genetics Consortium, under leading geneticist Doctor Ephrat Levy-Lahad.
The Prevention GENEration
program goals are to raise awareness and encourage testing for the BRCA hereditary mutation. These mutations run in families of Ashkenazi Jewish descent at a much higher rate than the general population. In the realm of national public policy, the program was successful in including the BRCA test in the Israeli health basket at no cost for all people of Ashkenazi descent. Previously it was only given if one person in the close family had tested positive for BRCA. This was a tremendous achievement for which Dr. Levy-Lahad won the EMET Prize in Israel.
To achieve its goals the program has a website in the page of the Israel Cancer Association that includes an online questionnaire in Hebrew and vast information on the topic including videos and brochures.